231 related articles for article (PubMed ID: 16044585)
1. Who's afraid of biotechnology?
Tait J
New Sci; 1992 Jun; 134(1827):49. PubMed ID: 16044585
[No Abstract] [Full Text] [Related]
2. Biologists mobilize against anti-genetics referendum.
Koenig R
Science; 1997 Jan; 275(5300):607-8. PubMed ID: 9019813
[No Abstract] [Full Text] [Related]
3. Britain opens biotech regulation to greater public involvement.
Masood E
Nature; 1999 May; 399(6734):287-8. PubMed ID: 10360555
[No Abstract] [Full Text] [Related]
4. Regulation as facilitation: negotiating the genetic revolution.
Black J
Mod Law Rev; 1998 Sep; 61(5):621-60. PubMed ID: 14518446
[No Abstract] [Full Text] [Related]
5. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
Krimsky S
Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
[No Abstract] [Full Text] [Related]
6. The governance of human genetics: policy discourse and constructions of public trust.
Jones M; Salter B
New Genet Soc; 2003 Apr; 22(1):21-41. PubMed ID: 15282897
[TBL] [Abstract][Full Text] [Related]
7. Recipe for disaster.
Nat Biotechnol; 2003 May; 21(5):465. PubMed ID: 12721554
[No Abstract] [Full Text] [Related]
8. The science and politics of plant biotechnology--a personal perspective.
Vasil IK
Nat Biotechnol; 2003 Aug; 21(8):849-51. PubMed ID: 12894193
[No Abstract] [Full Text] [Related]
9. The biotechnology revolution and its regulatory evolution.
Hoffman DE
Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
[No Abstract] [Full Text] [Related]
10. Asilomar's legacy in Aotearoa New Zealand.
Rogers-Hayden T
Sci Cult (Lond); 2005 Dec; 14(4):393-410. PubMed ID: 16622954
[No Abstract] [Full Text] [Related]
11. Transnationalizing recombinant-DNA regulation: between Asilomar, EMBO, the OECD, and the European Community.
Gottweis H
Sci Cult (Lond); 2005 Dec; 14(4):325-38. PubMed ID: 16619468
[No Abstract] [Full Text] [Related]
12. Genetic engineering regulation in Australia: an 'archaeology' of expertise and power.
Hindmarsh R
Sci Cult (Lond); 2005 Dec; 14(4):373-92. PubMed ID: 16622953
[No Abstract] [Full Text] [Related]
13. USDA scrutinizes GM organism regulations.
Fox JL
Nat Biotechnol; 2004 Mar; 22(3):254-5. PubMed ID: 14990936
[No Abstract] [Full Text] [Related]
14. Genetic engineering poses new containment challenges.
Krisberg K
Nations Health; 2004 Mar; 34(2):6. PubMed ID: 15255006
[No Abstract] [Full Text] [Related]
15. Russia readies its first gene law.
Allakhverdov A
Science; 1995 Jun; 268(5217):1558. PubMed ID: 7777849
[No Abstract] [Full Text] [Related]
16. Regulation of recombinant DNA research: a comparative study.
Teichmann DL
Loyola Los Angel Int Comp Law J; 1983; 6(1):1-35. PubMed ID: 15739273
[No Abstract] [Full Text] [Related]
17. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.
Van Overwalle G
Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104
[No Abstract] [Full Text] [Related]
18. A new window of opportunity to reject process-based biotechnology regulation.
Marchant GE; Stevens YA
GM Crops Food; 2015; 6(4):233-42. PubMed ID: 26930116
[TBL] [Abstract][Full Text] [Related]
19. Recombinant regulation: the Asilomar legacy 30 years on.
Hindmarsh R; Gottweis H
Sci Cult (Lond); 2005 Dec; 14(4):299-307. PubMed ID: 16619466
[No Abstract] [Full Text] [Related]
20. The sanctity of life in a brave new world: a manifesto on biotechnology and human dignity.
Council for Biotechnology Policy, USA
Hum Reprod Genet Ethics; 2003; 9(2):36-7. PubMed ID: 14964213
[No Abstract] [Full Text] [Related]
[Next] [New Search]
